Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Cas9 inhibits hepatitis C in human cells

05 May 2015

By Dr James Heather

Appeared in BioNews 800

US researchers have used the CRISPR/Cas9 system to target hepatitis C infection in human cells.

Researchers from Emory University had previously discovered a kind of Cas protein called FnCas9 that can reduce the amount of protein a gene produces by binding to the intermediate mRNA (messenger RNA). In this new study they demonstrate that this Cas enzyme can be co-opted to target the RNA genome of the hepatitis C virus (HCV), resulting in reduced production of viral proteins in human cells.

Using cells grown from a liver tumour, the study showed how DNA encoding the FnCas9 protein and the guide RNA that brings the enzyme to the viral genome were both required to inhibit HCV growth. This prevented expression of viral proteins if the Cas genes were delivered both before or after the cells were infected with HCV, the researchers report in PNAS.

The CRISPR/Cas system uses short guide-RNA sequences to target nucleic acid-degrading Cas enzymes towards specific DNA or RNA sequences. This ability makes it an incredibly versatile scientific tool.

It is hoped that as the CRISPR/Cas system evolved in bacteria to protect them from viruses that infect bacteria, viruses that infect eukaryotes, such as plants and animals, should not have evolved ways to escape their effects. Therefore this technique could theoretically be applied to a number of different medical or research scenarios.

'We can envision using Cas9-based technology to prevent viral infections in transgenic animals and plants, for example,' said senior author Dr David Weiss. 'This is a proof of principle that we can re-engineer Cas9 to target RNA in human or other mammalian cells.'

Weiss commented to BioPharma-Reporter that it is unclear if expressing Cas9 in humans will be safe. 'This is not something we are going to be jumping into,' he said.

However, he suggested that one potential use of the strategy could be in livestock for public health purposes.

'If pigs are infected with a virus, the virus can in some cases be transmitted to humans. You could make these pigs resistant to infection and that would break the cycle of transmission to people,' he said. 'That is one way it might offer an antiviral benefit.'

SOURCES & REFERENCES
Emory University | 27 April 2015
 
PNAS | 27 April 2015
 
The Scientist | 27 April 2015
 
GenomeWeb | 28 April 2015
 
BioPharma-Reporter | 05 May 2015
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

05 October 2015 - by Meghna Kataria 
Scientists have identified a new version of the gene-editing technique CRISPR, which could enable greater precision in the editing of genomes, while making its use simpler and more flexible...
03 August 2015 - by Lubna Ahmed 
Researchers have successfully used the technique CRISPR/Cas 9 to cut and paste genes into T-cells of the immune system...
18 May 2015 - by Ari Haque 
Patents for the gene-editing technology, CRISPR/Cas9, are the subject of a dispute between scientists at University of California, Berkeley and the Broad Institute of MIT and Harvard....
11 May 2015 - by Dr Calum MacKellar 
The short article by Robin Lovell-Badge entitled 'Editing human embryos' addressing the work of Junjiu Huang and colleagues in China on gene editing in human embryos - such as the use of the CRISPR/Cas9 system - raises a number of ethical questions....
11 May 2015 - by Dr Indrayani Ghangrekar & Ayala Ochert 
Molecular biologists have used gene-editing technology to identify promising targets for anti-cancer drugs...

27 April 2015 - by Ayala Ochert 
Chinese scientists report the first-ever genetic modification of human embryos using the CRISPR/Cas9 gene-editing technique, confirming rumours that these highly controversial experiments were underway...
27 April 2015 - by Professor Robin Lovell-Badge 
As Chinese scientists report the first gene editing of human embryos, is a moratorium on such practice justified?...
23 March 2015 - by Meghna Kataria 
Scientists have called for a worldwide moratorium on the use of the gene-editing technique CRISPR/Cas9 in human embryos and germ cells...
28 July 2014 - by Dr James Heather 
Research has shown that it may be possible to 'cut' the viral DNA out of cells infected by HIV using genetic editing techniques, removing its ability to replicate...
03 December 2012 - by Daryl Ramai 
Scientists have discovered a gene that controls the immune response against infection...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation